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Introduction
Strenuous endurance exercise and long-term endurance
training are associated with muscle adaptations and dam-
age, with reports of ultrastructural and morphological
changes2,9,15 as well as a systemic inflammatory response.39
Research has reported mobilization and activation of neu-
trophils,4,19 heightened leucocyte turnover,4 and a complex
pattern of pro- and anti-inflammatory cytokine release relat-
ed to muscle or tissue damage.27,41 Whether strenuous
endurance exercise affects the airway and systemic com-
partments similarly, and the possibility that it may cause
adpatations or damage at the airway level, are issues that
require further research.
It has been shown that strenuous endurance exercise
affects the airways by increasing the incidence of upper res-
piratory tract infections (URTIs) related to bacterial or viral
infections26,29 and respiratory symptoms such as exercise-
induced bronchoconstriction (EIB)1,16 or airway hyperrespon-
siveness (AHR).22,33 Whilst immunosuppression has been
related to the increase in URTIs,21 studies on airway cells and
inflammatory markers in endurance athletes have suggested
a possible association between airway inflammatory cells
and exercise-induced respiratory symptoms.5 Recently, it
was found that common viral and bacterial agents as well as
allergy/asthma were not responsible for upper respiratory
tract symptoms (URTS) reported 2 - 10 days after an ultra-
marathon race.37 The results suggested that the URTS symp-
toms may be due to mucosal inflammation in the upper
respiratory tract (URT), although airway inflammatory cells
and markers were not measured. 
Eosinophils have been recognised as URT pro-inflamma-
tory cells with a considerable tissue-injuring potential,42 and
have been shown to mediate damage to respiratory epitheli-
um as well as shedding of bronchial epithelium leading to tis-
sue damage.17 Eosinophil cationic protein (ECP) is an
eosinophil granule-derived protein and serum ECP is regard-
ed as a highly sensitive marker of eosinophil activation in the
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Abstract
Objective. To determine the effect of prolonged
endurance exercise on the serum concentrations of
eosinophil cationic protein (ECP), immunoglobulin E (IgE)
and upper respiratory tract symptoms (URTS).
Design. In 11 healthy, experienced volunteers (6 males, 5
females, age 43 ± 9.8 years) the serum concentrations of
ECP and IgE were measured, 24 hours prior to projected
finishing time, immediately post exercise (IPE), and 3 h,
24 h, and 72 h after an ultramarathon (90 km). Self-report-
ed URTS were also recorded for 14 days after the race.
ECP was measured using radioimmunoassay and IgE
using the Alastat Microplate Total IgE kit. The after-exer-
cise values were corrected for plasma volume changes,
which were calculated from haematocrit and haemoglobin
values. Serum concentrations of ECP and IgE were
analysed using an analysis of variance (ANOVA) compar-
ing values with before-exercise levels. Level of signifi-
cance was set at p ≤ 0.05.
Results. ECP was significantly elevated at 72 hours
(+52%), whilst IgE was not significantly altered after the
ultramarathon. There were no reported URTS for the 14
days after the race.
Conclusion. The eosinophil is a pro-inflammatory leuko-
cyte involved in bronchial hyperreactivity and allergic
inflammation of the airways. IgE is associated with aller-
gic diseases such as asthma and rhinitis. Serum ECP is a
sensitive marker of eosinophil activation. The result pro-
vides evidence for the non-allergic activation of blood
eosinophils during prolonged endurance exercise.
Whether this indicates exercise or environmentally
induced airway inflammation, or a role for ECP in muscle
/tissue repair, are hypotheses that require additional
research.
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URT.43 ECP plays an important role in the pathogenesis of
URT allergic inflammation11 and asthma, where it is released
in response to allergen-immunoglobulin E (IgE) crosslink-
ing.14 Recently, it was reported that a dietary deficiency of
antioxidant vitamins may play a role in increasing the sever-
ity of asthma.24 Bowler amd Crapo6 suggested that augmen-
tation of existing antioxidant defences with catalytic
antioxidants might be useful in attenuating respiratory disor-
ders through counteracting the effects of inflammatory cells
such as airway eosinophils.  Similarily, it has been reported
that antioxidant supplementation may reduce the incidence
of URTI after ultramarathon running.30 However, Bowler and
Crapo6 concluded that the use of antioxidants in the treat-
ment of airway reactions requires further study. Recently, it
was shown that the use of airway anti-inflammatory medica-
tion reduced the self-reported incidence of URTS in ultrama-
rathon runners.36
Only two previous studies have reported that eosinophils
may be activated by non-allergic mechanisms in healthy sub-
jects. Both prolonged endurance exercise11 and short-term
maximal exercise12 were shown to increase serum ECP in
healthy subjects. There is therefore, limited data on the
response of eosinophils to a physiological challenge such as
endurance exercise, and the possibility that these cells may
be associated with the URTS reported after endurance exer-
cise in non-allergic/asthmatic individuals is yet to be
explored. The aim of the study was therefore to monitor
eosinophil activation by measuring serum ECP, a possible
allergic involvement through measuring alterations in serum
IgE, and the association that alterations in these serum pro-
teins may have with URTS after an ultramarathon. 
Methods
Subjects
Eleven experienced runners (6 males, 5 females) from local
running clubs and who had entered the 2002, 90 km
Comrades ultramarathon, volunteered to participate in this
study.
Exclusion criteria
Subjects who reported that they smoked or suffered from
asthma, allergic rhinitis, respiratory disease or had an URTI
in the week leading up to the ultramarathon were excluded.
The protocol was approved by the Tshwane Institute of
Technology Ethics Committee, and informed consent was
obtained from each subject.
Medication and nutritional supplements
Subjects were asked to abstain from the use of anti-inflam-
matory and anti-histamine medication.  The use of multivita-
mins and anti-oxidants was not controlled.  However, the
subjects recorded their dietary and supplement intake for 2
weeks before and 2 weeks after the Comrades to help con-
trol for the possible effect of multivitamin and anti-oxidant
intake on results.
Study design
The subjects reported to the exercise testing laboratory 2
weeks before the race where they completed questionnaires
relating to their health history, training schedule (distance run
in the past 6 months), and ultramarathon experience.
Following completion of the questionnaires, body composi-
tion and cardiorespiratory fitness were determined.
Body composition
Height and weight were recorded using a calibrated medical
height gauge and balance scale (Detecto, Webb City, USA).
A Harpenden skinfold caliper was used for skinfold mea-
surements (7 sites) to assess body composition using the
Drinkwater-Ross method.34
Maximal oxygen uptake and heart rate
Subjects were instructed to abstain from high-intensity or
long-duration training sessions the day prior to being tested.
In addition they were instructed to eat a light meal three
hours prior to the VO2max. testing. The test was performed on
a Quinton 90 treadmill (Quinton Instrument Co., Seattle,
Washington). Continuous respiratory measurements were
recorded by means of the MedGraphics CardiO2 combined
VO2 /ECG exercise system (Medical Graphics Corporation,
Chicago, Illinois). Heart rate response was monitored using
a Polar Heart rate monitor. The test began at 8 km/h on a 3%
incline, for 5 minutes. Thereafter, speed and gradient were
increased at 1 km/h and 1% respectively every minute. From
12 km/h, only the gradient  was increased by 1% per minute
until exhaustion.23 Standard criteria were used to ensure
attainment of VO2max.32
Ultramarathon testing
Upper respiratory tract symptoms
Twenty-four hours prior to the projected finishing time the
runners completed a questionnaire on their state of health
during the 2 weeks leading up to the race. For 2 weeks after
completion of the race the subjects completed a daily ques-
tionnaire regarding the severity and duration of URTS. The
questionnaire included a scale which assessed the severity
and duration of self-reported URTS such as a running nose,
sneezing, sore throat, and cough.29
Blood draws
Venous blood samples (15 ml) were collected 24 hours prior
to projected finishing time, and then within 10 minutes imme-
diately post exercise (IPE), and 3 h, 24 h, and 72 h after the
ultramarathon. Five millilitres of blood were collected in glass
vacutainer tubes containing the anticoagulant, tripotassium
ethylenediaminetetraacetic acid (k3-EDTA) and were used to
determine full blood counts. Ten millilitres were collected in
serum separator tubes which remained at room temperature
for 30 minutes. These tubes were then centrifuged for 10
minutes and the serum was divided into 0.5 ml aliquots and
stored at –80°C until analysis.
Haematological adjustments
Full blood counts were performed on k3-EDTA-treated spec-
imens using standard haematological procedures on an
automated STKS model (Coulter Electronics Inc., Hialeah,
Florida, USA). Plasma volume changes were determined
from pre- and post-race haemoglobin and haematocrit val-
ues using the method of Dill and Costill.10
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Determination of ECP and IgE
Serum ECP concentrations were determined using a
radioimmunoassay technique (ECP-RIA, Pharmacia,
Stockholm, Sweden) as described by Peterson et al.31 Serum
ECP was considered normal within the range of 2 - 15 µg/l.
The total serum IgE (normal range, 22 - 86 KU/I) was deter-
mined with the use of the Alastat Microplate Total IgE kit
(Diagnostic Products, USA) according to the manufacturer's
instructions and by comparison with a known range of stan-
dard IgE concentrations. High and low control samples were
run for both assays, and all samples were analysed in tripli-
cate.  To avoid inter-assay variability, all samples from each
subject were assayed on the same microtitre plate.
Statistical analysis
Results are expressed as means ± SE. Data were analysed
using commercial software (SAS Institute, Cary, NC) using
an analysis of variance (ANOVA), contrasting variables to
baseline values. Tukey’s post hoc tests were use to deter-
mine significant differences attributed to time. The level of
significance was set at p < 0.05.
Results
Subjects
Demographic data on the runners are shown in Table I. The
subjects in the study were experienced ultramarathon run-
ners having completed an average of 4 ultramarathons. The
average distance covered in training in preparation for the
ultramarathon was 1 377.3 km (January - June). The aver-
age time taken to complete the race (9.45 h ± 1.1) indicates
that the athletes were not in the elite category. The cut-off
time for the race is 11 hours, with the top 10 runners usually
completing the 90 km under 6 hours. There were no reports
of URTS in the 2 weeks prior to or after the ultramarathon.
The dietary and supplement records did not reveal excessive
intake of multivitamins or anti-oxidants.
Serological parameters
The before and after-race levels of ECP (normal < 15 ug/l)
and IgE (normal range 22 - 85 KU/l) were within clinically
normal reference ranges. All after-race exercise concentra-
tions of ECP and IgE were corrected for exercise-induced
plasma volume changes before statistical analysis.
Eosinophil cationic protein level began rising immediately
after the ultramarathon. Fig. 1 shows that the ECP level was
significantly increased (+52%) at 72 h (p = 0.03) compared
with the before-exercise level. There was no significant alter-
ation in IgE concentration after the ultramarathon (Fig. 2).
Discussion
Strenuous endurance exercise causes significant stress to
the respiratory system, from the associated hyperventilation,
as well as increased airway exposure to contaminants of
inhaled air3,7,25,40 such as allergens or pollutants.18 URTS have
been linked with bacterial or viral infection during an ‘open-
window period’, 3 - 72 hours after exercise where an 
individual is susceptible due to exercise-induced immuno-
suppression.21 Recently, it was hypothesised that URTS after
an ultramarathon may not be due to bacterial or viral infec-
tion or allergy,37 with the results suggesting that mucosal
URT inflammation may be the source of URTS. The present
study investigated the effects of an ultramarathon on
immune parameters, which could be associated with post-
exercise URTS.
TABLE I. Subject characteristics 
Parameter Mean (± SD)
Age (years) 43 (± 10)
Height (cm) 170 (± 10)
Weight (kg) 64 (± 13)
Body fat (%( 14 (± 3)
VO2 max (ml/kg/min) 57.5 (± 6)
HRmax (beats/min) 172 (± 15)
Weekly training distance (km/wk) 58 (± 17)
Race time (hours) 9.45 (± 1.1)
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Fig. 1. Alterations in serum eosinophil cationic protein
(µg/l) of 6 male and 5 female subjects following an ultra-
marathon. Signifies p < 0.05 compared with before race
levels.
Fig. 2. Alterations in serum immunoglobulin E (KU/I) of 6
male and 5 female subjects following an ultramarathon.
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Eosinophil cationic protein was significantly increased 72
hours after the ultramarathon (Fig. 1) whilst IgE was not sig-
nificantly altered (Fig. 2). These data suggest a non-allergic
activation of blood eosinophils after strenuous endurance
exercise. Recently, a similar elevation in serum ECP was
reported to provide evidence for a moderate generation of
bronchial hyperreactivity in healthy individuals after pro-
longed endurance exercise.11 A subclinical, non-allergic
inflammation associated with eosinophil activation within the
airways was suggested to be responsible for the increase in
bronchial reactivity.11 It was proposed that intense prolonged
mouth breathing of cold, dry air during exercise might have
been responsible for increased respiratory water loss and
subsequent osmotic challenge to the bronchial epithelium.
Damaged epithelial cells might then have attracted circulat-
ing eosinophils to the airway mucosa via the release of the
cytokines interleukin-5 (IL-5) and tumour necrosis factor-α.
These eosinophils subsequently degranulated with the
release of ECP, which caused further damage and inflam-
mation in the respiratory epithelium.11 This is a possible
explanation for the raised serum ECP in the present study. 
Although bronchial hyperactivity was not measured and
there were no reported clinical URTS for the 2 weeks after
the ultramarathon, the raised serum ECP levels in both stud-
ies suggest the possibility that an acute bout of strenuous
endurance exercise may cause weak mucosal URT inflam-
mation. This inflammation may be similar in nature to that
found in a process called ‘minimal persistent inflammation’
(MPI) that has been demonstrated in both mite-induced and
pollen-induced rhinitis8 and asymptomatic allergic subjects.28
Although the URTS questionnaire has been used success-
fully in the past to identify URTS30 it is possible that a more
sensitive questionnaire is required to identify self-reported
symptoms/manifestations of minimal airway inflammation.
The questionnaire used was biased towards URTI symptoms
and therefore a future study should look at validating a ques-
tionnaire that is sensitive to symptoms of airway inflamma-
tion.  An additional explanation for the lack of reported URTS
is the small sample size.  A larger sample size may have
increased the probability of more subjects with URTS. The
authors therefore do not rule out the possibility of URTS
related to the presence of ECP in the present study. Whether
frequent episodes of such non-allergic ECP peaks create a
higher risk in healthy individuals for developing exercise-
induced and allergic asthma/rhinitis over time, or increased
after-exercise reporting of URTI-like symptoms, are ques-
tions that remain unanswered.
Short maximal exercise has also been shown to cause a
non-allergic activation of eosinophils in healthy individuals.
Plasma ECP was shown to be elevated immediately after a
graded maximal bicycle exercise test.12 Two possible expla-
nations for eosinophil activation were provided which are
related to exercise-induced muscle/tissue damage. Firstly,
that ECP is usually released by eosinophils to deal with non-
phagocytosable opsonised micro-organisms (e.g. para-
sites).20 It was speculated that during strenuous exercise
non-phagocytosable muscle/tissue fragments are liberated
accounting, in analogy to the defence against parasites, for
the eosinophil activation and ECP release. The second
explanation was that ECP has been shown to participate in
muscle/tissue repair processes by modifying the production
of glycosaminoglycans by human fibroblasts.35 These two
explanations are feasible for the present study as strenuous
endurance exercise has been reported to cause muscle / tis-
sue damage2,9,15,41 that requires removal and repair. The acute
phase response (APR) to muscle/tissue damage, specifical-
ly the activation of complement components C3, C4 and C5
fragments, may be a possible mechanism for activating
eosinophils.13 Submitted data from the present study have
shown that the same ultramarathon caused an APR and an
increase in complement,38 and this may have played a role in
the non-allergic activation of eosinophils.
Conclusions
The finding that ECP was elevated after the ultramarathon
leads to various hypotheses that require testing. Firstly, that
non-allergic eosinophil activation is maladaptive and that fre-
quent episodes of subclinical exercise-induced ECP peaks in
healthy individuals might result in MPI and the development
of exercise-induced or allergic asthma/rhinitis. Secondly, that
non-allergic eosinophil activation represents a normal physi-
ological adaptive response of the immune system to the
presence of non-phagocytosable muscle/tissue fragments
and that eosinophils are activated to assist with removal and
repair. Thirdly, that the URTS reported after exercise by indi-
viduals may not be the result of infection but rather due to
mucosal URT inflammation induced by activated inflamma-
tory cells in the URT. Further studies are therefore necessary
to test these hypotheses and at the same time aim to deter-
mine, in terms of inflammatory processes in the URT: (i) the
exercise dose-response; (ii) the role of environmental factors
in determining different airway cell patterns; (iii)  the time-
course and features of training-induced adaptations, and (iv)
long-term effects of exercise training, and their possible
impact on respiratory health.5
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